Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Bites and Stings × Etanercept × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 2 Stomatitis 1 Neoplasms 1 Neoplasm Metastasis 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Juvenile 1 Leukemia 1 Inflammation 1 Fatigue Syndrome, Chronic 1 Bone Neoplasms 1 Bites and Stings 1 Arthritis, Rheumatoid 1

Interventions

pembrolizumab 2 Immune Checkpoint Inhibitors 2 Cytochrome P-450 Enzyme System 2 enzalutamide 1 blinatumomab 1 abiraterone 1 Hydroxyurea 1 Etanercept 1 Androgen Receptor Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03792841 2025-10-16

Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC

Amgen

Phase 1 Terminated

Bites and Stings, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡